Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange Therapy

NCT02095821 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT02095821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange Therapy
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Terminated
Start date
February 28, 2014
Completion date
October 31, 2019
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clotting disorder due to plasma exchange therapy, humoral rejection after kidney transplantation